Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
YWHAQ pseudogene 4 (YWHAQP4) is classified as a pseudogene in the human genome, related by sequence similarity to the YWHAQ gene encoding the 14-3-3 protein theta[4][5]. Pseudogenes do not produce functional proteins and typically lack characterized biological roles, disease associations, or drug interactions. There is no evidence in available databases of any functional protein product, receptor activity, enzymatic role, or established medical relevance for this locus. If the intended query concerned YWHAQ, that gene encodes a signal transduction adapter critical for cellular regulation, but YWHAQP4 itself does not share those properties[1][2][3][4][5]. Summary of findings: - YWHAQP4 represents a non-coding pseudogene. - It does not encode a receptor, enzyme, or other therapeutic target. - It is not used as a biomarker and has no known disease or drug relevance. - If you are seeking information about the 14-3-3 protein theta (YWHAQ), refer to YWHAQ, not YWHAQP4[1][2][3]. - The target is not valid for therapeutic or functional study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on YWHAQ pseudogene 4 (YWHAQP4).